(Q33356682)

26 July 2017

title

Identification of low intratumoral gene expression heterogeneity in neuroblastic tumors by genome-wide expression analysis and game theory (English)

1 reference

26 July 2017

1 reference

Paola Scaruffi

2

0 references

Simona Coco

object named as

Simona Coco

4

0 references

Claudio Di Cristofano

object named as

Claudio Di Cristofano

6

0 references

Stefano Bonassi

object named as

Stefano Bonassi

9

0 references

author name string

Domenico Albino

1

1 reference

26 July 2017

Stefano Moretti

3

1 reference

26 July 2017

Mauro Truini

5

1 reference

26 July 2017

Andrea Cavazzana

7

1 reference

26 July 2017

Sara Stigliani

8

1 reference

26 July 2017

Gian Paolo Tonini

10

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 September 2008

1 reference

26 July 2017

1 reference

26 July 2017

volume

113

1 reference

26 July 2017

issue

6

1 reference

26 July 2017

page(s)

1412-1422

1 reference

Variance stabilization applied to microarray data calibration and to the quantification of differential expression

26 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23720

Gene expression profiling and identification of novel prognostic marker genes in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23720

7 January 2021

Prediction of clinical outcome using gene expression profiling and artificial neural networks for patients with neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23720

7 January 2021

Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23720

7 January 2021

Expression profiling and characterization of 4200 genes cloned from primary neuroblastomas: identification of 305 genes differentially expressed between favorable and unfavorable subsets

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23720

7 January 2021

Customized Oligonucleotide Microarray Gene Expression–Based Classification of Neuroblastoma Patients Outperforms Current Clinical Risk Stratification

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23720

7 January 2021

Genome analysis and gene expression profiling of neuroblastoma and ganglioneuroblastoma reveal differences between neuroblastic and Schwannian stromal cells

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23720

7 January 2021

Significance analysis of microarrays applied to the ionizing radiation response

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23720

7 January 2021

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23720

7 January 2021

affy--analysis of Affymetrix GeneChip data at the probe level

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23720

7 January 2021

Alternative mapping of probes to genes for Affymetrix chips

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23720

7 January 2021

Expression profiling of favorable and unfavorable neuroblastomas.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23720

7 January 2021

Altered expression of cell cycle genes distinguishes aggressive neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23720

7 January 2021

Oligonucleotide microarray analysis of gene expression in neuroblastoma displaying loss of chromosome 11q.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23720

7 January 2021

High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23720

7 January 2021

Significance of survivin mRNA expression in prognosis of neuroblastoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23720

7 January 2021

The AP-2 family of transcription factors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23720

7 January 2021

Numerical and structural aberrations in advanced neuroblastoma tumours by CGH analysis; survival correlates with chromosome 17 status

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23720

7 January 2021

Translocations of 17q21 approximately qter in neuroblastoma cell lines infrequently include the topoisomerase IIalpha gene.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23720

7 January 2021

Molecular cytogenetic delineation of 17q translocation breakpoints in neuroblastoma cell lines.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23720

7 January 2021

Prediction of doxorubicin sensitivity in breast tumors based on gene expression profiles of drug-resistant cell lines correlates with patient survival.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23720

7 January 2021

Topotecan and etoposide in the treatment of relapsed high-risk neuroblastoma: results of a phase 2 trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23720

7 January 2021

Protease activation in apoptosis induced by MAL

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23720

7 January 2021

Mitotic arrest, apoptosis, and sensitization to chemotherapy of melanomas by methionine deprivation stress.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23720

7 January 2021

Clusterin and DNA repair: a new function in cancer for a key player in apoptosis and cell cycle control

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23720

7 January 2021

Temporally regulated neural crest transcription factors distinguish neuroectodermal tumors of varying malignancy and differentiation.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.23720

7 January 2021

Identifiers

DOI

10.1002/CNCR.23720

1 reference

26 July 2017

1 reference